Clinical Trials Directory

Trials / Completed

CompletedNCT07449260

Association Between Serum Thyroid-stimulating Hormone (TSH) and Intracytoplasmic Sperm Injection (ICSI) Outcome in Women Undergoing ICSI

Is TSH Level in Serum Affect ICSI Outcome?

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

TSH has been suggested to be involved in reproductive challenges such as ovulatory issues, infertility, miscarriage, and maternal complications for many years. Multiple studies have associated thyroid function with ovarian function and reproductive physiology. The thyroid hormone can impact follicle development, as well as the metabolism of estrogen and androgen, the menstrual cycle, and the receptivity of the endometrium

Detailed description

In a region with adequate iodine levels, a TSH threshold of 4.12 mIU/L should be regarded as the upper limit of normal. The Chinese Society for Reproductive Medicine suggests that infertile women and those trying to conceive should consider a TSH level between 4-4.5 mIU/L for subclinical hypothyroidism. Hence, it is recommended that women aiming for in vitro fertilization (IVF) should have a TSH level of 4 mIU/L or lower. Studies have shown that infertile patients with untreated TSH levels \>2.5 mIU/L before IVF/intracytoplasmic sperm injection (ICSI) had better pregnancy results when their TSH levels were \<2.5 mIU/L compared to those with TSH \>2.5 mIU/L. In this study the aim was to Examine the clinical characteristics and results in infertile individuals with varying thyroid stimulating hormone (TSH) levels during ICSI, and determining which TSH levels cutoff impact the outcomes of ICSI or not.

Conditions

Interventions

TypeNameDescription
OTHERBasal TSH levelOn day 2-3 of spontaneous cycles, all planned women for ICSI cycle had basal TSH level measurment

Timeline

Start date
2019-01-01
Primary completion
2024-12-01
Completion
2025-02-01
First posted
2026-03-04
Last updated
2026-03-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07449260. Inclusion in this directory is not an endorsement.